CR11824A - Derivados heterocíclicos de la urea y sus métodos de empleo - Google Patents

Derivados heterocíclicos de la urea y sus métodos de empleo

Info

Publication number
CR11824A
CR11824A CR11824A CR11824A CR11824A CR 11824 A CR11824 A CR 11824A CR 11824 A CR11824 A CR 11824A CR 11824 A CR11824 A CR 11824A CR 11824 A CR11824 A CR 11824A
Authority
CR
Costa Rica
Prior art keywords
urea
heterocyclic derivatives
employment methods
employment
methods
Prior art date
Application number
CR11824A
Other languages
English (en)
Inventor
Brian Sherer
Fei Zhou
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40848376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11824(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR11824A publication Critical patent/CR11824A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen compuestos químicos, compuestos de fórmula (I) y sus sales farmacéuticamente aceptables. Se describen también procesos para su preparación.
CR11824A 2008-06-04 2010-12-03 Derivados heterocíclicos de la urea y sus métodos de empleo CR11824A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5872808P 2008-06-04 2008-06-04
US15409309P 2009-02-20 2009-02-20

Publications (1)

Publication Number Publication Date
CR11824A true CR11824A (es) 2011-01-12

Family

ID=40848376

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11824A CR11824A (es) 2008-06-04 2010-12-03 Derivados heterocíclicos de la urea y sus métodos de empleo

Country Status (22)

Country Link
US (1) US20090325902A1 (es)
EP (1) EP2313402A1 (es)
JP (1) JP2011522030A (es)
KR (1) KR20110019737A (es)
CN (1) CN102105468A (es)
AR (1) AR072046A1 (es)
AU (1) AU2009254937A1 (es)
BR (1) BRPI0913583A2 (es)
CA (1) CA2725572A1 (es)
CL (1) CL2009001345A1 (es)
CO (1) CO6351722A2 (es)
CR (1) CR11824A (es)
DO (1) DOP2010000374A (es)
EA (1) EA201001859A1 (es)
EC (1) ECSP10010659A (es)
IL (1) IL209500A0 (es)
MX (1) MX2010013251A (es)
PE (1) PE20091959A1 (es)
TW (1) TW201002728A (es)
UY (1) UY31865A (es)
WO (1) WO2009147440A1 (es)
ZA (1) ZA201008609B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011121555A1 (en) 2010-03-31 2011-10-06 Actelion Pharmaceuticals Ltd Antibacterial isoquinolin-3-ylurea derivatives
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2012007836A1 (en) 2010-07-16 2012-01-19 Purdue Pharma .Lp. Pyridine compounds as sodium channel blockers
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
WO2014096941A1 (en) 2012-12-20 2014-06-26 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
CN106866571B (zh) * 2017-01-20 2018-06-29 中国药科大学 杂环脲类化合物及其药物组合物和应用
US20210070747A1 (en) 2017-03-24 2021-03-11 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135953A (en) * 1984-12-28 1992-08-04 Ciba-Geigy Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals
DK1341769T3 (da) * 2000-12-15 2008-01-28 Vertex Pharma Bakterielle gyrase-inhibitorer og anvendelser deraf
CN101171247A (zh) * 2005-03-04 2008-04-30 阿斯利康(瑞典)有限公司 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物
ES2363178T3 (es) * 2006-12-04 2011-07-26 Astrazeneca Ab Compuestos de urea policíclicos antibacterianos.

Also Published As

Publication number Publication date
US20090325902A1 (en) 2009-12-31
JP2011522030A (ja) 2011-07-28
PE20091959A1 (es) 2010-02-13
AR072046A1 (es) 2010-08-04
WO2009147440A1 (en) 2009-12-10
CN102105468A (zh) 2011-06-22
BRPI0913583A2 (pt) 2015-10-27
AU2009254937A1 (en) 2009-12-10
CA2725572A1 (en) 2009-12-10
EP2313402A1 (en) 2011-04-27
DOP2010000374A (es) 2011-01-15
ZA201008609B (en) 2011-08-31
TW201002728A (en) 2010-01-16
UY31865A (es) 2010-01-29
IL209500A0 (en) 2011-01-31
CL2009001345A1 (es) 2010-06-11
MX2010013251A (es) 2010-12-21
KR20110019737A (ko) 2011-02-28
CO6351722A2 (es) 2011-12-20
EA201001859A1 (ru) 2011-08-30
ECSP10010659A (es) 2011-01-31

Similar Documents

Publication Publication Date Title
CR11824A (es) Derivados heterocíclicos de la urea y sus métodos de empleo
ECSP10010419A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
ECSP11011183A (es) Compuestos orgánicos
ECSP11011184A (es) Compuestos orgánicos
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
ECSP077271A (es) Derivados de pirimidina
ME01488B (me) Derivati oksadiazola i njihovo korišćenje kao potencijatora metabotropnih glutamatnih receptora-842
DOP2010000047A (es) Compuestos de pirazol y su uso como inhibidores de raf
UY32296A (es) Nuevos compuestos
ECSP077259A (es) Derivados de pirimidina
ATE445593T1 (de) Acetylenderivate
UY33075A (es) Derivados de ciclohexano y usos de los mismos
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
ECSP10010664A (es) Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UA106880C2 (uk) Нові гербіциди
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
CL2012000278A1 (es) Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)